Bioprocess Data Signing via External Units to Prevent Manipulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprocess data integrity is vulnerable to manipulation, particularly in biotechnological and biopharmaceutical processes, necessitating improved methods to ensure data integrity with low effort.

Innovation Solution

A digital control unit with a local processor and storage unit initiates a signing routine using an external signing unit, employing asymmetric cryptography to generate digital signatures for bioprocess data, ensuring data integrity by controlling the signing process and minimizing opportunities for manipulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing signing methods are used to ensure data integrity, then data manipulation is prevented, but the system remains vulnerable to manipulation within the bioprocess laboratory

Engineering Contradiction:
Improvedata integrityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system segments the signing process into distinct components: a signing routine that is initiated by the digital control unit but executed externally. This separation isolates the critical signing function from the potentially compromised laboratory environment, enhancing data integrity without requiring complete system redesign

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

An external signing unit acts as an intermediary between the bioprocess data and the signing function. This intermediary executes the signing routine outside the vulnerable laboratory environment, providing an additional layer of protection against manipulation while maintaining system functionality

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If complex technologies like distributed ledger technology are implemented, then data integrity is enhanced, but hardware and system complexity increases

Engineering Contradiction:
Improvedata integrityVSAvoidhardware requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The critical signing function is extracted from the complex distributed ledger technology framework and implemented as a standalone routine that can be executed by simple external units. This extraction achieves data integrity protection without requiring the full infrastructure of complex blockchain systems

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system uses simple, inexpensive external signing units that can be easily deployed and replaced if needed, rather than investing in complex, expensive distributed ledger infrastructure. The signing routine itself serves as a lightweight, disposable solution that achieves the security goal without heavy hardware requirements

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Loss of information

If existing signing methods are used, then data documentation is maintained, but manipulation opportunities remain within the laboratory

Engineering Contradiction:
Improvedata documentationVSAvoiddata manipulation resistance
Core Design Contradiction:
Loss of informationVSReliability

Solution Approach 1:

The signing routine is initiated by the digital control unit before the data leaves the controlled environment, establishing an early seal on the data integrity. This preliminary signing action creates a trusted reference point that prevents subsequent manipulation while maintaining complete data documentation

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements a feedback mechanism where the digital control unit initiates the signing routine based on the bioprocess data, and the execution status is fed back to confirm successful signing. This closed-loop approach ensures both documentation is maintained and manipulation is prevented through verified signing execution

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12445456B2Method for conducting a bioprocess
Publication Date: 2025.10.14 SARTORIUS STEDIM BIOTECH GMBH
  • US12445456B2 patent drawing
  • US12445456B2 patent drawing
  • US12445456B2 patent drawing

AI summary

A method for conducting a bioprocess with a digital control unit of a bioprocess arrangement, wherein the digital control unit comprises a local data storage and a local processor unit, wherein the digital control unit comprises a bioprocess interface for sending and receiving bioprocess control data, wherein bioprocess data are generated by the digital control unit, wherein a bioprocess control routine is executed by the local processor unit to control the bioprocess, wherein in the bioprocess control routine, the bioprocess data are generated by the digital control unit from actuator data and/or sensor data and/or user control command data. It is proposed that a signing routine is initiated by the local processor unit in the data safety routine to be executed by an external signing unit(s).